Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX

Betz Stephen F. disposed of 137,936 Crinetics Pharmaceuticals, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 1, 2026

On Sep 1, 2026, Betz Stephen F. (Chief Scientific Officer) disposed of 137,936 Crinetics Pharmaceuticals, Inc. shares at US$85.00 for US$11.7M, leaving 0 shares. Filed Sep 1, 2026 (Form 4).

Disposed of
137,936 shares
Price
US$85.00
Value
US$11.7M
Holding after
0 shares
Trading plan
No
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockDisposition58,286US$85.0079,650Direct
Sep 1, 2026Common StockDisposition79,650US$85.000Direct

Source

View original at SEC

Related